Your email has been successfully added to our mailing list.

×
-0.0103806228373702 -0.013840830449827 -0.0242214532871972 -0.055363321799308 -0.0951557093425605 -0.114186851211073 -0.117647058823529 -0.14878892733564
Stock impact report

Enzo Bio up 19% premarket on launch of COVID-19 blood test [Seeking Alpha]

Enzo Biochem, Inc. ($0.01 Par Value) (ENZ) 
Last enzo biochem, inc. ($0.01 par value) earnings: 12/7 04:10 pm Check Earnings Report
US:NYSE Investor Relations: enzo.com/corporate/investor-information
Company Research Source: Seeking Alpha
Enzo Biochem (NYSE:ENZannouncesEnzo is currently offering COVID-19 test kits under the FDA’s Emergency Use Authorization (EUA) authority, which uses its proprietary GENFLEX open diagnostic platform.The new COVID-19 test features improved scale, sensitivity, and more relevant positive control materials.Shares are up19% Show less Read more
Impact Snapshot
Event Time:
ENZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
ENZ alerts

from News Quantified
Opt-in for
ENZ alerts

from News Quantified